tailieunhanh - A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

Programmed cell death-1 (PD-1) immune checkpoint inhibitor antibody has proven to be effective in advanced non-small cell lung cancer (NSCLC) patients positive for programmed cell death-1 ligand-1 (PD-L1). However, there are currently no prospective studies evaluating PD-L1 expression for small biopsy samples. | A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN